HopeStage
Back to all studies
RecruitingNCT07123467

Cannabidiol with CBT for generalized anxiety

About this titleRead the official source — NCT07123467
Medication studyAges 18–45United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 45 years.

What will I do during this study?

You receive a five-week course of brief cognitive behavioural therapy. Depending on your randomly assigned group, this is combined with a lower or moderate dose of oral cannabidiol (EPIDIOLEX) or a matching inactive placebo solution.

Listed locations
DetroitSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: November 3, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
90
Sponsor
Wayne State University
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 18 Years to 45 Years
Official registry ID
NCT07123467
Official title
Show the full official title

Cannabidiol-Enhanced Cognitive Behavioral Therapy for Generalized Anxiety Disorder

Recruitment & locations

Currently recruiting

Detroit

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Wayne State University, a university.

Does this study involve medication?

Yes. The study involves medication, including Low-Dose Cannabidiol, Placebo Matched to Moderate-Dose Cannabidiol, Moderate-Dose Cannabidiol and Placebo Matched to Low-Dose Cannabidiol.

Who can participate?

Listed age limits: 18 years to 45 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies